pharma

Showing 15 posts of 2914 posts found.

bernie_in_phoenix_2015_2

Sanders calls on Trump to support drug pricing bill

January 11, 2019
Medical Communications Bernie Sanders, Trump, access, pharma, pricing

Senator Bernie Sanders has called on President Donald Trump to support new legislation aimed at cutting prices on prescription drugs. …

astrazeneca-sign

AstraZeneca to shut down twin Colorado manufacturing sites, impacting over 200 jobs

January 10, 2019
Manufacturing and Production AstraZeneca, US, job cuts, pharma

UK-based drug firm AstraZeneca has revealed it is set to shed more than 200 positions from its operations at two …

NICE rejects Novartis’ Aimovig migraine injection for NHS use

January 10, 2019
Sales and Marketing Aimovig, NICE, Novartis, migraine, pharma

It’s disappointing news for Novartis as NICE revealed that it had decided not to recommend Aimovig (erenumab) for routine NHS …

bonecells

Amgen and UCB’s Evenity approved in Japan for osteoporosis

January 9, 2019
Research and Development, Sales and Marketing Amgen, Japan, UCB Pharma, osteoporosis, pharma

Amgen has revealed that its bone-forming monoclonal antibody Evenity (romosozumab), developed in partnership with UCB Pharma, has been awarded approval …

Death row inmate whose execution was postponed found dead in cell

January 9, 2019
Research and Development Alvogen, Scott Dozier, execution, pharma, prison

Scott Dozier, the death row inmate whose execution was stalled by court cases launched by pharmaceutical companies, has been found …

Pfizer to shutter two manufacturing plants in India, 1,700 jobs at risk

January 9, 2019
Manufacturing and Production, Research and Development India, Pfizer, pharma

Pfizer has announced it is to shut down two of its manufacturing facilities in India – a move which could …

nicola_redfern

bluebird bio reveals new UK General Manager

January 9, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bluebird Bio, appointment, pharma

bluebird bio, a US-based gene therapy biotech with a focus on cancer and severe genetic conditions,  has named Nicola Redfern …

heart-2372134_640

Two biomarkers can aid in atrial fibrillation screening, researchers find

January 8, 2019
Manufacturing and Production, Research and Development University of Birmingham, atrial fibrillation, biomarkers, pharma

A team of researchers at the University of Birmingham has identified a pair of biomarkers which it says could aid …

takeda_global_hq

Takeda completes Shire acquisition

January 8, 2019
Manufacturing and Production M&A, MA, Shire, Takeda, acquisition, deal, pharma

Japanese firm Takeda Pharmaceuticals has successfully completed its acquisition of Shire Plc. The long anticipated deal has propelled the firm …

cancer-vs-alzheimer-1080x810

Roche’s Genentech inks potential $2bn personalised cancer drug development deal

January 7, 2019
Sales and Marketing Adaptive Biotechnologies, Cancer, Genentech, Roche, oncology, pharma

Roche’s Genentech is set to enter into a deal with Adaptive Biotechnologies to bolster its pursuits in the treatment of …

How tech is powering precision treatment

January 7, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, Precision Medicine, pharma, tech

As the scientific community eschews scattergun approaches and demand rises for higher-quality, targeted care, Matt Fellows explores how technologies such …

shutterstock_36423250

Promising interim Phase 3 data spurs epidermolysis bullosa trial expansion for Amryt

January 7, 2019
Research and Development, Sales and Marketing Amryt, epidermolysis bullosa, pharma, rare disease

Rare disease firm Amryt has announced interim efficacy data for its epidermolysis bullosa (EB) therapy AP101, showing that things are …

ipos0_l

Sanofi will pay Regeneron $582m in deal restructuring

January 7, 2019
Sales and Marketing Deals, Regeneron, Sanofi, biotech, pharma

French pharmaceutical giant Sanofi will pay US biotech Regeneron $582 million, as part of a restructuring of an earlier deal …

stocks1

Aevi Genomic Medicine’s share price crashes 75% following ADHD trial failure

January 4, 2019
Medical Communications, Research and Development ADHD, AEVI-001, Aevi Genomic Medicine, clinical trial failure, pharma

Aevi Genomic Medicine, a US drugmaker based outside of Philadelphia, has seen its share value plummet by 75% following the …

astrazeneca_sign_sky

NICE recommends AstraZeneca’s Fasenra as third treatment option for severe asthma

January 4, 2019
Medical Communications, Sales and Marketing AstraZeneca, Fasenra, NHS, NICE, UK, asthma, pharma

It’s good news for both asthma patients and AstraZeneca after UK drug watchdog NICE saw fit to recommend the drugmaker’s …

The Gateway to Local Adoption Series

Latest content